<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0" 
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:admin="http://webns.net/mvcb/"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

<channel>
<title>Biojournals.com Latest Ovarian Cancer Publications</title>
<link>http://www.biojournals.com/Ovarian Cancer.html</link>
<description>Latest publications on Ovarian Cancer</description>

<language>en-us</language> 
<managingEditor>biojournals@sci7.com</managingEditor> 
<sy:updatePeriod>hourly</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>
<sy:updateBase>2000-01-01T12:00+00:00</sy:updateBase>
<item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22308459</link> <title>Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin</title><description>      but inhibited by Mullerian inhibiting substance. Women with late-stage ovarian cancer usually develop ...  
http://dx.doi.org/10.1073/pnas.1120733109 

Proc Natl Acad Sci U S A. 2012 Jan 27. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22308434</link> <title>Ecotopic viral integration site 1 (EVI1) regulates multiple cellular</title><description>      processes important for cancer and is a synergistic partner for FOS      protein in invasive tumors. Ecotropic viral integration site 1 (EVI1) is an oncogenic dual domain zinc ...  
http://dx.doi.org/10.1073/pnas.1119229109 

Proc Natl Acad Sci U S A. 2012 Jan 19. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22307839</link> <title>Reprogramming tumor-associated dendritic cells in vivo using microRNA</title><description>      mimetics triggers protective immunity against ovarian cancer. Modulating the activity of microRNAs (miRNAs) provides opportunities for ...  
http://dx.doi.org/10.1158/0008-5472.CAN-11-3160 

Cancer Res. 2012 Feb 3. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22307431</link> <title>[Ovarian mucinous borderline cystoadenoma, in a premenarchal girl].</title><description> Ovarian epithelial tumors (cystoadenomas/cystoadenocar-cinomas) are not as ...  
http://dx.doi.org/10.1590/S0325-00752012000100014 

Arch Argent Pediatr. 2012 Feb;110(1):e4-8. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22307331</link> <title>The use of androgens or androgen-modulating agents in poor responders</title><description>      undergoing in vitro fertilization: a systematic review and meta-analysis. BACKGROUNDThe aim of this meta-analysis was to evaluate the role of ...  
http://dx.doi.org/10.1093/humupd/dmr051 

Hum Reprod Update. 2012 Feb 3. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22307137</link> <title>A Phase I Study of Veliparib in Combination with Metronomic</title><description>      Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas. PURPOSE:  Oral administration of the alkylating agent cyclophosphamide at ...  
http://dx.doi.org/10.1158/1078-0432.CCR-11-2821 

Clin Cancer Res. 2012 Feb 3. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22306997</link> <title>BRCA1-directed, enhanced and aberrant homologous recombination: Mechanism</title><description>      and potential treatment strategies. Despite intense studies, questions still remain regarding the molecular ... 
Cell Cycle. 2012 Feb 15;11(4). </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22306908</link> <title>Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer:  A Pilot Study.</title><description> The objective was to evaluate the toxicity and feasibility of ...  
http://dx.doi.org/10.1097/CJI.0b013e318243f213 

J Immunother. 2012 Feb;35(2):196-204. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22306838</link> <title>Liver resection for liver metastases from nondigestive endocrine cancer:</title><description>      Extrahepatic disease burden defines outcome. BACKGROUND: For patients with hepatic nondigestive endocrine metastases ...  
http://dx.doi.org/10.1016/j.surg.2011.12.025 

Surgery. 2012 Feb 3. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22306526</link> <title>Estrogen receptor alpha overexpressing mouse antral follicles are</title><description>      sensitive to atresia induced by methoxychlor and its metabolites. Methoxychlor (MXC) and its metabolites bind to estrogen receptors (ESRs) ...  
http://dx.doi.org/10.1016/j.reprotox.2012.01.007 

Reprod Toxicol. 2012 Jan 28. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22306204</link> <title>Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer</title><description>      cells and spheroids is impacted by differential AKT activity. OBJECTIVE: We propose that metastatic epithelial ovarian cancer (EOC) is a ...  
http://dx.doi.org/10.1016/j.ygyno.2012.01.048 

Gynecol Oncol. 2012 Feb 1. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22306178</link> <title>Depletion of ascorbic acid impairs NK cell activity against ovarian cancer</title><description>      in a mouse model. Ascorbic acid (Vitamin C) administration has been used to prevent ...  
http://dx.doi.org/10.1016/j.imbio.2011.12.010 

Immunobiology. 2012 Jan 2. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22306097</link> <title>[Atypical polypoid adenomyoma: Retrospective study about 8 cases from</title><description>      Jeanne-de-Flandre Hospital between 1996 and 2008.] OBJECTIVES: To propose a therapeutic approach and follow-up of patients ...  
http://dx.doi.org/10.1016/j.gyobfe.2011.08.003 

Gynecol Obstet Fertil. 2012 Feb 3. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22305543</link> <title>Synthesis and evaluation of anticancer activity of some novel</title><description>      6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones. A series of novel pyridazinone derivatives bearing benzenesulfonamide ...  
http://dx.doi.org/10.1016/j.ejmech.2012.01.026 

Eur J Med Chem. 2012 Jan 20. </description></item><item>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22305456</link> <title>Ovarian incidentaloma.</title><description> Incidental adnexal masses occur with relatively high frequency in ...  
http://dx.doi.org/10.1016/j.beem.2011.07.002 

Best Pract Res Clin Endocrinol Metab. 2012 Feb;26(1):105-16. </description></item>
 </channel>
</rss>

